Concepedia

Naoko Kaniwa

NK

Statistics

Publications

5

Citations

153

H-Index

5

Active since

2001

Affiliations

National Institute of Health Sciences(Current)

National Institute of Infectious Diseases

Naoko Kaniwa is an author at National Institute of Health Sciences specializing in pharmacology, cytochrome p450-mediated metabolism, and medicine.

Publications per year

2001–2006

5

Publications

5

An analytical method for irinotecan (CPT‐11) and its metabolites using a high‐performance liquid chromatography: parallel detection with fluorescence and mass spectrometry

Kimie Sai, Naoko Kaniwa, Shogo Ozawa et al. · Biomedical Chromatography · 2002 · 41 citations

Medicine, Oncology, Pharmacology +17

A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4.

Kimie Sai, Naoko Kaniwa, Shuichi Ozawa et al. · PubMed · 2001 · 36 citations

Medicine, Biochemistry, Pharmacology +17

Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer

Y. Nakajima, Takashi Yoshitani, Hiromi Fukushima‐Uesaka et al. · Clinical Pharmacology & Therapeutics · 2006 · 34 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Liquid chromatographic–atmospheric pressure chemical ionization mass spectrometric analysis of opiates and metabolites in rat urine after inhalation of opium

Ruri Kikura‐Hanajiri, Naoko Kaniwa, Mikako Ishibashi et al. · Journal of Chromatography B · 2003 · 31 citations

Pharmacy, Pharmacology, Toxicology +10

Expression of CYP2A6 in Tumor Cells Augments Cellular Sensitivity to Tegafur

Norie Murayama, Kimie Sai, Yukiko Nakajima et al. · Japanese Journal of Cancer Research · 2001 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 5